According to Morphic Therapeutic's latest financial reports the company's current EPS (TTM) is -$3.24. In 2022 the company made an earnings per share (EPS) of -$1.57 an increase over its 2021 EPS that were of -$2.67.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.24 | 106.37% |
2022 | -$1.57 | -41.2% |
2021 | -$2.67 | 82.88% |
2020 | -$1.46 | -75.13% |
2019 | -$5.87 | 463.85% |
2018 | -$1.04 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -91.67% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -69.14% | ๐บ๐ธ USA |